Nov 9 (Reuters) - Swedish Orphan Biovitrum  SOBIV.ST :
    * SOBI SUCCESSFULLY COMPLETES TENDER OFFER FOR ALL
OUTSTANDING
SHARES OF DOVA PHARMACEUTICALS
    * CO'S UNIT DRAGONFLY SUCCESSFULLY COMPLETED ITS TENDER
OFFER TO
BUY ALL OUTSTANDING SHARES OF DOVA FOR $27.50 PER SHARE
    * UPON COMPLETION OF MERGER, DOVA WILL BECOME AN INDIRECT
WHOLLY
OWNED SUBSIDIARY OF SOBI
    * TENDER OFFER TO BUY DOVA'S ALL SHARES FOR $27.50 PER
SHARE, NET
TO SELLER THEREOF IN CASH, WITHOUT INTEREST

Source text for Eikon:  ID:nWkr5Tk4s3 
Further company coverage:  SOBIV.ST 

 ((Reuters.Briefs@thomsonreuters.com;))